Frontiers in Immunology

Tuesday, 13 November 2012

IMPACT GUARANTEE HIGH QUALITY GUARANTEE FAST PUBLISHING GUARANTEE MY FRONTIERS ACCOUNT
Three million page views every month.
Seven million article views and downloads.
An average paper receives thousands of views and hundreds of downloads within weeks.
Track your impact in real-time from your very own Frontiers account.
Frontiers continuously strives to be the highest quality open access option for your paper.
Our editors all rank in the top 5% of the world’s impact scientists.
The real time review and unlimited iterations with reviewers ensure top standards for every paper.
High quality copy-editing and type-setting guarantees you the best production process.
The most advanced, custom-designed and automated IT publishing platform.
Papers go into review within 20 minutes of submission.
Accepted papers pass through to acceptance in 30–90 days.
Pre-prints may be published during review if it is clear the paper will pass.
Accepted papers are published on-line within two weeks.
The best quality high speed publishing guaranteed.
Build and display your scientific profile and get into the Who’s Who of Medicine.
Organize and track all your publications.
Launch Events.
Start your own science Blog.
Post Images, Videos and News.
Advertise and search for Jobs.
» See your impact   » Submission options   » Author guidelines   » Register now
Frontiers Article Alert
Frontiers in Immunology is pleased to announce a number of exciting new articles:
Frontiers in Antigen Presenting Cell Biology
Published on 7 November 2012
Novel Murine Dendritic Cell Lines: A Powerful Auxiliary Tool for Dendritic Cell Research
Silvia A. Fuertes Marraco, Frédéric Grosjean, Anaïs Duval, Muriel Rosa, Christine Lavanchy, Devika Ashok, Sergio Haller, Luc A. Otten, Quynh-Giao Steiner, Patrick Descombes, Christian A. Luber, Felix Meissner, Matthias Mann, Lajos Szeles, Walter Reith, and Hans Acha-Orbea
Frontiers in Immunological Memory
Published on 8 November 2012
Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens
Yuan Zhao, Vikas Tahiliani, Shahram Salek-Ardakani, and Michael Croft
Published on 9 November 2012
Local immunity by tissue-resident CD8+ memory T cells
Thomas Gebhardt and Laura K. Mackay
Frontiers in Inflammation
Published on 1 November 2012
Macrophages in inflammation and its resolution
Amiram Ariel, Isabelle Maridonneau-Parini, Patrizia Rovere-Querini, Jerrold S. Levine, and Heiko Mühl
Published on 8 November 2012
NOD1 and NOD2 Signaling in Infection and Inflammation
Lilian O. Moreira and Dario S. Zamboni
Frontiers in Microbial Immunology
Published on 30 October 2012
Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction
Claudia M. Calvet, Tatiana G. Melo, Luciana R. Garzoni, Francisco O. R. Oliveira Jr., Dayse T. Silva Neto, Maria N. S. L., L. Meirelles, and Mirian C. S. Pereira
Published on 6 November 2012
Regulation and use of the extracellular matrix by Trypanosoma cruzi during early infection
Pius N. Nde, Maria F. Lima, Candice A. Johnson, Siddharth Pratap, and Fernando Villalta
Published on 8 November 2012
Sculpting humoral immunity through dengue vaccination to enhance protective immunity
Wayne D. Crill, Holly R. Hughes, Nicole B. Trainor, Brent S. Davis, Matt T. Whitney, and Gwong-Jen J. Chang
Frontiers in Molecular Innate Immunity
Published on 5 November 2012
Manipulating the Lewis antigen specificity of the cholesterol-dependent cytolysin lectinolysin
Sara Lawrence, Susanne Feil, Jessica Holien, Michael Kuiper, Larissa Doughty, Olan Dolezal, Terrence Mulhern, Rodney Tweten, and Michael Parker
Published on 12 November 2012
Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis
Daigo Nakazawa, Utano Tomaru, Chiho Yamamoto, Satoshi Jodo, and Akihiro Ishizu
Frontiers in Mucosal Immunity
Published on 7 November 2012
The role of Peyer’s patches in synchronizing gut IgA responses
Nils Y. Lycke and Mats Bemark
Frontiers in NK Cell Biology
Published on 1 November 2012
Role of KIR3DS1 in human diseases
Christian Körner and Marcus Altfeld
Published on 9 November 2012
Human NK cell lytic granules and regulation of their exocytosis
Konrad Krzewski and John E. Coligan
Frontiers in Tumor Immunity
Published on 30 October 2012
Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells
Agnete B. Fredriksen, Inger Sandlie, and Bjarne Bogen
Published on 6 November 2012
Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements
Maha Z. Ladjemi
Published on 8 November 2012
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
Valeria I. Segatori, Ana M. Vazquez, Daniel E. Gomez, Mariano R. Gabri, and Daniel F. Alonso
Published on 9 November 2012
Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins
Alejandro López-Requena, Oscar R. Burrone, and Michela Cesco-Gaspere
Connect with us on Facebook LinkedIn Follow the latest articles of
Frontiers in Immunology
Twitter RSS
Frontiers in Immunology  |  Science Park PSE-D  |  1015 Lausanne  |  Switzerland  |  +41 21 693 92 02  |  info@frontiersin.org  |  www.frontiersin.org
Feel free to suggest your colleagues to stay in touch with our news and sign in here.